Transactions in Connection with Share Buy-back Program
June 10, 2024 10:18 ET
|
Genmab A/S
Company Announcement COPENHAGEN, Denmark; June 10, 2024 – Genmab A/S (Nasdaq: GMAB). On March 15, 2024, Genmab announced the initiation of a share buy-back program to repurchase up to DKK 3.5...
Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifene’s Preclinical Effects on Aromatase Inhibitor Resistant Non-ESR1 Mutated Breast Cancer
June 10, 2024 10:17 ET
|
Sermonix Pharmaceuticals Inc.
In preclinical mouse models, results suggested lasofoxifene could be an effective therapy for all hormone treatment-resistant breast tumorsPhase 3 ELAINE-3 study is currently investigating...
Clinical Decision Support Systems (CDSS) Market Surges to USD 3.76 Billion by 2031, Propelled by 11.9% CAGR - Verified Market Research®
June 10, 2024 10:15 ET
|
Verified Market Research
Lewes, Delaware, June 10, 2024 (GLOBE NEWSWIRE) -- The Global Clinical Decision Support Systems (CDSS) Market is projected to grow at a CAGR of 11.9% from 2024 to 2031, according to a new report...
Lowey Dannenberg, P.C. is Investigating Akero Therapeutics, Inc. (“Akero”) (NASDAQ: AKRO) for Potential Violations of the Federal Securities Laws and Encourages Investors with Losses to Contact the Firm
June 10, 2024 10:14 ET
|
Lowey Dannenberg, P.C.
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Akero Therapeutics, Inc. (“Akero”)...
Biopharmaceutical Market to Reach USD 1,829.2 Billion by 2033, Growing at 15.4% CAGR | Dimension Market Research
June 10, 2024 10:12 ET
|
Dimension Market Research
New York, June 10, 2024 (GLOBE NEWSWIRE) -- Overview: The Global Biopharmaceutical Market size reached USD 436.7 billion in 2023 and is further anticipated to reach USD 1,829.2 billion by 2033...
Ovarian Cancer Pipeline Drugs Analysis, 2024: Insights on 180+ Companies and 200+ Pipeline Drugs, Including Atezolizumab (Genentech), Tisotuma Vedotin (Genmab), and SON-1010 (Sonnet Biotherapeutics)
June 10, 2024 10:11 ET
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
NDSS, Orson, and Joy of Mom Partner to Create an Unforgettable Father's Day Gift to Support the Down Syndrome Community
June 10, 2024 10:09 ET
|
National Down Syndrome Society
Washington D.C., June 10, 2024 (GLOBE NEWSWIRE) -- The National Down Syndrome Society (NDSS) has joined forces, with Orson, the groundbreaking AI video storytelling platform, and Joy of Mom, a...
Leader Dogs for the Blind Offers Their Free Programs in Spanish to U.S. and Canadian Individuals who are Blind or Visually Impaired
June 10, 2024 10:08 ET
|
Leader Dogs for the Blind
Rochester Hills, Michigan, June 10, 2024 (GLOBE NEWSWIRE) -- Leader Dogs for the Blind is proud to announce they are expanding their free Guide Dog and Orientation & Mobility (O&M) programs...
Lowey Dannenberg Notifies Fastly, Inc. (“Fastly” or the “Company”) (NYSE: FSLY) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
June 10, 2024 10:08 ET
|
Lowey Dannenberg, P.C.
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
Lowey Dannenberg Notifies Vestis Corporation (“Vestis” or the “Company”) (NYSE: VSTS) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
June 10, 2024 10:07 ET
|
Lowey Dannenberg, P.C.
NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
- June 10, 2024 10:08 ET Leader Dogs for the Blind Offers Their Free Programs in Spanish to U.S. and Canadian Individuals who are Blind or Visually Impaired
- June 10, 2024 10:00 ET Helicopters Global Business Report 2024: Increased Demand for Luxurious and Custom-made Helicopters in the Transportation Industry